Since hyperketonemia can be induced by intermittent fasting, ketogenic diets, and various medications such as sodium glucose co‐transporter 2 inhibitors [27, 49, 50, 51], it would be of value to investigate how ketone bodies regulate different cell types within adipose tissue during the development of obesity. The gene discussed is SLC5A2; the disease is obesity disorder.